2006 Accounts
Financial accounts
Balance sheet as of December 31, 2006
2006 (Euro) | 2005 (Euro) |
|
ASSETS |
|
|
Current assets |
|
|
Debtors | 10,229 | 40,141 |
Subsidies due (EC) | 10,363 | |
Cash at bank and on deposit | 141,014 | 100,616 |
161,606 | 140,757 |
|
Accruals | 354 | 120 |
161,960 | 140,877 |
|
LIABILITIES | ||
Capital and reserves | ||
Results brought forward | 73,445 | 83,745 |
Result of the year | 16,724 | - 10,300 |
90,169 | 73,445 |
|
Creditors | ||
Payments received on account | 45,557 | 30,000 |
Trade creditors | 15,660 | 20,172 |
Other liabilities | 10,573 | 17,260 |
71,790 | 67,432 |
|
Accruals | ||
161,960 | 140,877 |
Profit and loss account – Year ended December 31, 2006
2006 (Euro) | 2005 (Euro) |
|
Support and revenue | ||
Subsidies from the EC | 233,270 | |
Other operating income | ||
Co-financing in kind | 203,155 | 114,885 |
Corporate sponsorship | 183,176 | 165,415 |
Sponsorship received on account | 45,557 | |
AE Conference | 58,597 | 10,000 |
Membership fees | 41,250 | 40,000 |
Other sponsorship/Subsidies | 24,325 | 6,391 |
Publication sales and royalties | 7,059 | 12,012 |
Other operating revenue | 6,120 | 4,834 |
Internet services | 5,815 | 5,925 |
Donations | 57 | 1,500 |
External charges | ||
External experts | - 335,668 | - 119,591 |
AE Conference | - 53,558 | |
Travel & Accommodation | - 93,586 | - 60,170 |
Publication and Information material | - 29,629 | - 19,859 |
Other costs | - 24,307 | - 574 |
Office rent and associated costs | - 22,291 | - 22,887 |
Communication costs | - 19,473 | - 17,828 |
Equipment & Leasing | - 8,363 | - 13,248 |
Office stationery and related costs | - 2,692 | - 1,810 |
Membership fees | - 750 | - 700 |
Irrecoverable debt | - 937 |
|
Staff costs | ||
Wages and salaries | - 85,491 | - 88,670 |
Social security costs | - 23,324 | - 24,322 |
Interest receivable and similar income | 974 | 581 |
Interest payable and similar charges | - 2,387 | - 1,247 |
16,724 | -10,300 |
Declaration of interests
Platinum donors and sponsors (Donations and sponsorship from €50,000)
Alzheimer Europe is grateful to Association Luxembourg Alzheimer and the Luxembourg Ministry for Family for the secondment of the Executive Director of Alzheimer Europe and the office space they make available to the organisation free of charge.
Gold donors and sponsors (Donations and sponsorship between €20,000 and €49,999)
Alzheimer Europe is grateful to GlaxoSmithKline, Janssen-Cilag, Lundbeck and Pfizer which generously agreed to support the activities Alzheimer Europe carried out in the framework of its business plan in 2006.
Furthermore, Alzheimer gratefully acknowledges the support it has received from Lundbeck for the organisation of a carers’ survey in France, Germany, Poland, Scotland and Spain and from GlaxoSmithKline for the support of delegates to the AE conference in Paris and a workshop on the company’s research activities in the Alzheimer’s field.
Silver donors and sponsors (Donations and sponsorship between €5,000 and €19,999)
Alzheimer Europe gratefully acknowledges the support of Numico for its contribution to the European Parliament event of Alzheimer Europe and for the organisation of a workshop on the company’s research activities in the Alzheimer’s field.
Alzheimer Europe is grateful for the generous contribution of Fondation Médéric Alzheimer to the Eurocode project of Alzheimer Europe.
Alzheimer Europe is grateful to Novartis and Merck Sharp & Dohme for their support to the activities of Alzheimer Europe.
Bronze donors and sponsors (Donations and sponsorship between €1,000 and €4,999)
Alzheimer Europe is grateful to Mazars for having carried out the audit of the 2005 financial accounts of the organisation free of charge.
Support from corporate sponsors
In 2006, Alzheimer Europe had an audited income of 763,798€. Sponsorship by the pharmaceutical industry and other corporate sponsors amounted to 183,176€ or 23.98%. The following table lists sponsorship and donations received by individual companies, as well as other payments, such as speakers’ fees, honoraria and support for travel or subsistence costs. The global support received from individual companies is also presented in terms of percentages of the overall income of the organisation in line with the policy of the European Medicines Agency with regard to the transparency requirements for patients’ organisations.
Company | Sponsorship and donations | Other payments | TOTAL | % of AE income |
Lundbeck | 30,000€ | 12,224€ | 42.224€ | 5.53% |
Janssen-Cilag | 40,000€ | 40,000€ | 5.24% |
|
Pfizer | 35,000€ | 1,361€ | 36,361€ | 4.76% |
GlaxoSmithKline | 25,000€ | 1,300€ | 26,300€ | 3.44% |
Novartis | 15,000€ | 1,723€ | 16,723€ | 2.19% |
Merck Sharp & Dohme | 7,891€ | 7,891€ | 1.03% |
|
APIFARMA | 1,529€ | 1,529€ | 0.20% |
|
EFPIA | 744€ | 744€ | 0.10% |
|
Roche | 319€ | 319€ | 0.04% |
|
Drug Information Association | 158€ | 158€ | 0.02% |
|
Sub-total: Support by the pharmaceutical industry | 172.249€ | 22.55% |
||
Numico | 10,000€ | 10,000€ | 1.31% |
|
GE Healthcare | 927€ | 927€ | 0.12% |
|
Sub-total: Support by other corporate sponsors | 10,927€ | 1.43% |
||
Total: Support by corporate sponsors | 183,176€ | 23.98% |
Last Updated: Wednesday 19 January 2011